Management of complicated parapneumonic effusions (Q40844464)

24 September 2017

1 reference

title

Management of complicated parapneumonic effusions (English)

1 reference

24 September 2017

Sahn SA

1

1 reference

24 September 2017

1 September 1993

1 reference

The American Review of Respiratory Disease

24 September 2017

1 reference

24 September 2017

148

1 reference

24 September 2017

3

1 reference

24 September 2017

813-817

1 reference

The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia

24 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

Pleural Fluid pH in Parapneumonic Effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

Immediate drainage is not required for all patients with complicated parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

The clinician's perspective on parapneumonic effusions and empyema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

Abnormalities of pathways of fibrin turnover in the human pleural space

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

Decreased Heat-Labile Opsonic Activity and Complement Levels Associated with Evidence of C3 Breakdown Products in Infected Pleural Effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

21 January 2018

Bacteriology of empyema

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

Pharmacokinetics and therapeutic efficacy of gentamicin in an experimental pleural empyema rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

The prognostic value of loculations in parapneumonic pleural effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

Empyema thoracis. Factors influencing morbidity and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F148.3.813

21 January 2018

Identifiers

DOI

10.1164/AJRCCM/148.3.813

1 reference

24 September 2017

1 reference

PubMed ID

8368654